Sanofi-Aventis SpA
Patent Owner
Stats
- 15 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Apr 08, 2014 most recent publication
Details
- 15 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 131 Total Citation Count
- May 19, 1986 Earliest Filing
- 2 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8691773 Peptide compound with biological activity, its preparation and its applicationsOct 06, 08Apr 08, 14[A61K, C07K]
8039006 Solid composition containing bacillus-type non-pathogenic bacterial sporesJul 26, 02Oct 18, 11[A61K, A01N, C12P]
6573366 Process for the purification of human interleukin-1 receptor antagonist from recombinant E. coliMay 09, 00Jun 03, 03[C12P, C07K]
6417350 Preparation of (11.beta.,16.beta.)-21-(3-carboxy-1-oxopropoxy)-11-hydroxy-2'-methyl-5'H-pregna-1,4-dieno [17,16-D]oxazole-3,20-dioneJan 20, 00Jul 09, 02[C07J]
6228851 Process for the purification of 11.beta.-21-dihydroxy-2'-methyl-5'.beta.H-pregna-1,4-dieno[17,16-D]oxazole-3,20-dioneAug 07, 98May 08, 01[A61K, C07J]
6103895 Preparation of (11.beta.,16.beta.)-21-(acetyloxy)-11-hydroxy-2'-methyl-5'H-pregna-1,4-d ieno[17,16-d]oxazole-3,20-dioneJun 05, 98Aug 15, 00[C07J]
5939523 Purification of dalbaheptide antibiotics by isoelectric focusingDec 18, 97Aug 17, 99[A61K, C07K]
5786350 36-derivatives of rifamycins and their use as antimicrobial agentsJan 31, 97Jul 28, 98[C07D, A61D]
Expired/Abandoned/Withdrawn Patents
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.